Skip to content

Medical-device intelligence

LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

FDA product code LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LON
FDA device name
System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
Device class
2
Regulation number
866.1645
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

293 clearance records and 240 recall records in the covered releases, across 22 source company names and 1 product codes. Dated history runs from Aug 1, 1986 to Nov 4, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202610
April 202610
May 202600
June 202603
July 202601
August 202602
September 202610
October 202610

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

533 matching records
Device / recordCompany in FDA recordSourceSource date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH GATIFLOXACIN (0.004-16 UG/ML)K023361 · LONDade Behring, Inc.510(k)Dec 16, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH MOXIFLOXACIN (0.004-16UG/ML)K023541 · LONDade Behring, Inc.510(k)Dec 13, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK023301 · LONBecton, Dickinson & CO510(k)Nov 12, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-AMIKACIN-0.5-64 UG/MLK023444 · LONBecton, Dickinson & CO510(k)Nov 12, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM - GENTAMICIN 0.25 - 16 UG/MLK023273 · LONBecton, Dickinson & CO510(k)Oct 31, 2002FDA decision date
VITEK GRAM POSITIVE SUSCEPTIBILITY (GPS) CARD FOR LINEZOLIDK022045 · LONbioMerieux, Inc.510(k)Aug 15, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK022172 · LONBecton, Dickinson & CO510(k)Aug 12, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM-CLINDAMYCIN 0.125-8.0MCG/MLK021954 · LONBecton, Dickinson & CO510(k)Aug 1, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM MOXIFLOXACIN 0.125-8 UG/MLK022129 · LONBecton, Dickinson & CO510(k)Jul 25, 2002FDA decision date
MICROSCAN SYNERGIES PLUS DRIED GRAM NEGATIVE MIC/COMBO PANELS WITH CEFTAZIDIME (1-16 UG/ML)K020413 · LONDade Behring, Inc.510(k)Jul 17, 2002FDA decision date
MICROSCAN RAPID/S PLUS GRAM-NEGATIVE MIC/COMBO PANELS WITH CEPHALOTHIN (2-64 UG/ML)K020410 · LONDade Behring, Inc.510(k)Jun 11, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK020321 · LONBecton, Dickinson & CO510(k)May 23, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN (0.25-128 UG/ML)K020398 · LONDade Behring, Inc.510(k)May 16, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH PIPERACILLIN (4-256 UG/ML)K020397 · LONDade Behring, Inc.510(k)Apr 22, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH AMPICILLIN/SULBACTAM (0.5/0.25-64/34 UG/ML)K020319 · LONDade Behring, Inc.510(k)Apr 17, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELS WITH CEFTRIAXONE (0.5-128 UG/ML)K020506 · LONDade Microscan, Inc.510(k)Apr 17, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK020323 · LONBecton, Dickinson & CO510(k)Apr 4, 2002FDA decision date
VITEK 2 ANTIMIRCROBIAL SUSCEPTIBILITY TEST SYSTEM FOR LEVOFLOXACINK020871 · LONbioMerieux, Inc.510(k)Mar 29, 2002FDA decision date
BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEMK020322 · LONBecton, Dickinson & CO510(k)Mar 27, 2002FDA decision date
VITEK 2 ANTIMICROBIAL SUSCEPTIBILITY TEST SYTEM FOR SPARFLOXACINK020870 · LONbioMerieux, Inc.510(k)Mar 25, 2002FDA decision date
MICROSCAN SYNERGIES PLUSK020142 · LONDade Behring, Inc.510(k)Mar 14, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TRIMETHOPRIM/SULFAMETHOXAZOLE (0.25/4.75-64/1216 UG/ML)K020248 · LONDade Behring, Inc.510(k)Mar 14, 2002FDA decision date
MICROSCAN SYNERGIES PLUSK020511 · LONDade Microscan, Inc.510(k)Mar 6, 2002FDA decision date
MICROSCAN SYNERGIES PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH CEFUROXIME (1-64 UG/ML)K020328 · LONDade Behring, Inc.510(k)Feb 19, 2002FDA decision date
MICROSCAN SYNERGIS PLUS GRAM NEGATIVE MIC/COMBO PANELS WITH TOBRAMYCIN (0.12-32 UG/ML)K020168 · LONDade Behring, Inc.510(k)Feb 6, 2002FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗